PrednisoneGraft RejectionRejection (Psychology)Kidney TransplantationVincristineImmunosuppressive AgentsTransplantation, HomologousHeart TransplantationGraft SurvivalCyclophosphamideGlucocorticoidsAzathioprineCyclosporineSkin TransplantationDoxorubicinProcarbazineAntineoplastic Combined Chemotherapy ProtocolsTreatment OutcomePrednisoloneTacrolimusMechlorethamineImmunosuppressionCorneal TransplantationDrug Therapy, CombinationLiver TransplantationLung TransplantationAntibodies, Monoclonal, Murine-DerivedAcute DiseaseTime FactorsMelphalanBiopsyDrug Administration ScheduleMitoxantroneAnti-Inflammatory AgentsTransplantation ImmunologyIsoantibodiesMethotrexateBleomycinFollow-Up StudiesCyclosporinsPancreas TransplantationAntilymphocyte SerumTransplantation ToleranceColor TherapyTissue DonorsTransplantation, HeterotopicRemission InductionRats, Inbred LewMethylprednisoloneRetrospective StudiesAdrenal Cortex HormonesTransplantation, IsogeneicComplement C4bChlorambucilLymphoma, Non-HodgkinHistocompatibility TestingAntibodies, MonoclonalRecurrenceSurvival AnalysisHodgkin DiseaseMice, Inbred C57BLLymphoma, Large B-Cell, DiffuseT-LymphocytesMycophenolic AcidMice, Inbred BALB CAdministration, OralPlasmapheresisSurvival RateBronchiolitis ObliteransOrgan TransplantationIsoantigensVinblastineAsparaginaseMultiple MyelomaThalidomideProspective StudiesChronic DiseaseIslets of Langerhans TransplantationKidneyRats, Inbred WFEtoposideDisease-Free SurvivalPrognosisCombined Modality TherapyPostoperative ComplicationsBone Marrow TransplantationClinical Trials as TopicHistocompatibilityNephrotic SyndromeTransplantation, HeterologousCadaverKeratoplasty, PenetratingImmune ToleranceGraft Enhancement, ImmunologicInfectionMethylprednisolone HemisuccinateDose-Response Relationship, DrugLiving DonorsPolymyalgia Rheumatica6-Mercaptopurine